Two major autoantibody clusters in systemic lupus erythematosus

Area of Science:

• Immunology
• Autoimmune Diseases
• Molecular Biology

Background:

• Systemic lupus erythematosus (SLE) is a complex autoimmune disease with diverse clinical presentations.
• Autoantibodies against nuclear proteins are key diagnostic markers for SLE.
• Current autoantibody profiling methods lack uniformity and scalability for disease sub-classification.

Purpose of the Study:

• To develop a uniform, quantitative platform for autoantibody profiling in SLE.
• To investigate the utility of autoantibody profiles for SLE sub-classification.
• To explore the association between autoantibody profiles and clinical manifestations in SLE.

Main Methods:

• Utilized the luciferase immunoprecipitation systems (LIPS) approach for serological profiling.
• Assessed autoantibodies against known SLE antigens (Sm-D3, RNP-A, RNP-70k, Ro52, Ro60, La) and other antigens.
• Analyzed autoantibody profiles in two independent patient cohorts.

Main Results:

• 88% and 98% of patients in two cohorts segregated into Sm/RNP or Ro/La autoantigen clusters.
• The Sm/RNP cluster showed a higher prevalence of serositis compared to the Ro/La cluster.
• Individual autoantibodies (anti-Sm, RNP-A, RNP-70k) associated with mucocutaneous symptoms; anti-RNP-70k with musculoskeletal manifestations.

Conclusions:

• Most SLE patients can be classified into Sm/RNP or Ro/La autoantigen clusters.
• These findings suggest a potential role for RNA-binding protein interactions in SLE pathogenesis.
• Autoantibody profiling may aid in understanding SLE heterogeneity and clinical associations.